Introduction
A regulated balance between cell proliferation and cell death is essential for tissue homeostasis, response to injury and prevention of carcinogenesis. p53, p21 and pRb are important inhibitory regulators of the cell cycle, and are effectors of cellular responses to injury which include cell cycle arrest and apoptosis.
pRb is a transcription cofactor that exerts antiproliferative activity by several mechanisms, in particular the direct inhibition of transcriptional activation by E2F, and active repression of gene expression by the Rb-E2F complex (Harbour et al. (2000a, b) and references therein). The p21 cyclin-dependent kinase inhibitor (CDKI) maintains pRb in a hypophosphorylated state that inhibits E2F-1 activity and thereby S-phase entry (Dotto (2000) and references therein). Upon phosphorylation of pRb, the Rb-E2F complex dissociates and genes involved in proliferation are expressed, allowing the G1/S transition to proceed.
The p53 tumor-suppressor protein regulates many cellular functions (Bargonetti et al., 2002) . In particular, it is critical for cell cycle arrest in response to DNA injury. After DNA damage, p53 is stabilized and activates the expression of target genes. Primary among these is p21 (Dotto (2000) and references therein), which provides a direct link between p53 and pRb for cell cycle arrest.
p53, p21 and pRb are associated with the regulation of apoptosis. A protective role for pRb was suggested upon examination of RbÀ/À embryos, which exhibit high levels of apoptosis in the central nervous system (Macleod et al., 1996) . Multiple mechanisms for this protective effect of pRb have since been suggested (Chau et al., 2002; Hickman et al. (2002) and references therein). p21 has been reported to have both positive and negative effects on apoptosis (Fotedar et al., 1999; Tsao et al., 1999; Jin et al., 2000; Goke et al. (2001) and references therein). Induction of both pro-and antiapoptotic genes by p21 may explain its dual effects (Chang et al., 2000) , together with its ability to inhibit kinases involved in the induction of apoptosis (Jin et al., 2000) and to prevent procaspase 3 activation by direct binding (Dotto (2000) and references therein). Inhibition of pRb phosphorylation could also contribute to the antiapoptotic activity of p21.
p53 can induce apoptosis in response to multiple stimuli, including DNA damage, withdrawal of growth factors and expression of cellular and viral oncogenes. There are two major apoptosis pathways, the mitochondrial and the death receptor pathways (for a recent review, see Bates et al., 1999) . p53 has been shown to induce the expression of proteins involved in both these pathways (Hickman et al. (2002) and references therein).
Attempts to better understand the roles and complex relationships of these three key proteins in the control of cell proliferation and apoptosis have been greatly helped with the analysis of cells bearing deletions of p53 or p21. However, the embryonic lethality of Rb deficiency (Clarke et al., 1992) has hindered investigation of the specific role played by pRb and the relative contribution of p53, p21 and pRb proteins to a specific cellular outcome. Using the Cre-Lox system for deletion of the Rb gene to provide primary hepatocytes knockout in all possible combinations of these three genes, we describe here the requirement for and interactions of p53, p21 and pRb proteins in controlling proliferation and apoptosis. We present a systematic comparison of proliferation, necrosis and apoptosis, and evaluation of cytologic abnormalities in single, double and triple knockout primary hepatocytes. The results show a requirement for p53, p21 and pRb proteins without redundancy, for the control of hepatocyte turnover.
It should be noted that for brevity, Rb-floxed cells infected by adenovirus-expressing Cre-recombinase will be referred as RbÀ/À cells, and p53À/Àp21À/ÀRbÀ/À cells are referred to as triple null cells (TRPL).
Results
p21, p53 and pRb regulate normal hepatocyte proliferation through at least three discrete pathways
In quiescent adult liver, almost all hepatocytes are in the G 0 phase, but isolation for primary culture primes the hepatocytes to enter G 1 in a near-synchronous manner. Around 72 h after plating, about 15% of wild-type hepatocytes enter the S phase (Bellamy et al., 1997) . We have already reported that Cre-mediated deletion of the Rb-floxed alleles from primary hepatocytes is rapid and efficient, using an adenovirus expressing Cre-recombinase: homozygous gene deletion is achieved within 16-24 h after infection (recombination greater than 95%) (Prost et al., 2001) . Indeed, regulation of an Rb-specific promoter plasmid is abolished within 48 h (Figure 1 ), making this technology suitable to evaluate the role of pRb in cell cycle regulation in primary hepatocytes.
Using immunodetection for BrdU incorporation at intervals after plating, we quantified the proportion of primary hepatocytes undergoing DNA synthesis. As expected, Cre-mediated deletion of Rb from wild-type hepatocytes increased the number of cells entering the S phase. In fact, Rb-deleted cells enter S phase earlier and maintain a higher rate of DNA synthesis throughout culture, compared to wild-type cells (Figure 2a, d ). This enhanced proliferation of RbÀ/À cultures was similar to that of p53À/À hepatocytes (Figure 2a, d) , with the first cells entering S phase at 48 h after plating (15-20%), and the proportion of cells in DNA synthesis steadily increasing. Interestingly, proliferation by p21À/À hepatocytes was even greater and accelerated, compared with RbÀ/À cultures, with up to 60% of the cells in S phase as early as 48 h after plating (Figure 2a, d) .
We next used double-and triple-mutant cells to evaluate the effect of combined deficiency of these genes on proliferation. The high proliferation rate of p21-deficient cells was not significantly changed when combined with p53 deficiency, regardless of Rb genotype (Figures 2b, d) . Thus, p53 deficiency did not modify the increased proliferation attributable to p21 deficiency. This is consistent with the known p53-p21 pathway being the only mechanism for p53 effect on hepatocytes cell cycle activity.
By contrast, the effect of pRb deficiency to further increase proliferation when added to either p53 or p21 deficiency, or both together (triple nulls), shows that there is cell cycle inhibition attributable to pRb that is independent of p21/p53 (Figures 2b, d ; compare p21À/À with double null (RbÀ/Àp21À/À) and double null (p53À/Àp21À/À) with triple null cells).
Finally, the observation that p21À/À cells show greater proliferation (Figure 2d ) than RbÀ/À cells, together with the additive effect of Rb and p21 deficiency on proliferation indicate that p21 protein has a greater impact on cell cycle inhibition, and suggest a particular property of p21 to inhibit early G1 exit independently of the other proteins.
Taken together, these results suggest that, firstly, each of these proteins is needed to maintain a normal constitutive restriction of cell cycle commitment in wild-type hepatocytes that are stimulated to proliferate. Secondly, these proteins exert cell cycle inhibition both independently and in concert: the data imply a p53-p21 pathway, a p21-pRb pathway, and further independent activities for both p21 and pRb but not p53 (summary Figure 7) .
Rb deletion induces p53 stabilization and p53-dependent upregulation of p21 pRb deletion in hepatocytes was associated with a dramatic accumulation of p53 protein, as found in other cell types (Macleod et al., 1996) : after 72 h culture, 70% of RbÀ/À cells were p53-immunopositive, compared 
Rb-deficient cells show increased polyploidization, nuclear abnormality and aberrant mitoses
Some Rb-deficient cells contained enlarged nuclei compared to wild-type cells. To determine whether this reflected an increased DNA content, we performed flowcytometric analysis on both wild-type and RbÀ/À cells, and extended the comparison to other null genotypes. Hepatocyte nuclear ploidy in normal mouse liver can range from 2n to over 32n, depending on age (Gupta (2000) and references therein). Hepatocytes isolated from the liver of 12-week-old mice used in this experiment are mainly binucleated cells (about 80% of the cells) with either two 2n (diploid) or 4n (tetraploid) nuclei. In culture, we found that some primary hepatocytes become multinucleated -with 3-10 nuclei -and fusion of cells in vitro has been observed by video microscopy (Prost, unpublished data). To p53-, p21-and Rb-deficient liver cells S Sheahan et al prevent this phenomenon impeding our study, we analysed the ploidy of isolated nuclei rather than cells. Loss of Rb, p53 deficiency or p21 deficiency, increased polyploidization (Figure 4 ) (21, 23 and 29% of octoploid (8n) nuclei in RbÀ/À, p53À/À and p21À/À versus only 8.5% of wild-type nuclei). Combining Rb deficiency with either p53 or p21 deficiency had an additive effect of increasing polyploidization compared with single nulls. By contrast, p53 deficiency reduced the ploidy level of all p21À/À genotypes (Figure 4 : compare triple null cells with double null (p21À/ÀRbÀ/À) (gray bars); then compare double null (p21À/Àp53À/À) with p21À/À white bars). Therefore, p21 deficiency requires functional p53 for a maximal effect on polyploidization.
We also noticed that many Rb-and p53-deficient hepatocytes developed severe cytological abnormalities of the nuclei, including pleomorphism, micronucleation (Figure 5a, b) . Quantification showed that the proportion of abnormal nuclei in RbÀ/À and p53À/À cultures increased with time (Figure 5a ), in parallel with increasing rates of DNA synthesis and mitosis. Interestingly, p21À/À cells, treated or not with Cre-adenovirus, did not develop nuclear abnormalities (Figure 5a, b) . This shows that the observed abnormalities appear rapidly (within 144 h, corresponding to a maximum of two cell cycles only), and are directly related to the gene defect studied rather than a consequence of Creexpression, as was documented with long-term (many months) high-level cre-expression (Silver et al., 2001) .
Coordinated regulation of both DNA and centrosome duplication is required for bipolar spindle formation and correct segregation of chromosomes during mitosis . As p53 and pRb have been shown to be involved in centrosome duplication (Meraldi et al., 1999; Mussman et al., 2000; Borel et al., 2002; Tarapore et al., 2002) , we postulated that, in cells lacking p53 or Rb, dysregulation of both proliferation and centrosome duplication would favor the formation of multipolar spindles and abnormal segregation of chromosomes causing the observed nuclear and mitotic abnormalities. In accordance with the literature, we found that the number of centrosomes in cells lacking p53 was significantly higher than in wild-type cells (averages7s.d. are 2.370.3 and 3.070.4 for mononucleated wild-type and p53À/À cells, respectively, P ¼ 0.0061, and 3.070.7 and 4.271.0 for binucleated cells, P ¼ 0.0122). By contrast, cells lacking Rb (or p21) showed no difference with control ( Figure 6 ).
Discussion
Isolation and primary culture of hepatocytes is a model for the passage from quiescence to a proliferative state that occurs during liver regeneration. Clearly, the present study shows a complex interplay between p53, p21 and pRb, which regulates the likelihood of hepatocytes stimulated from quiescence, to proliferate, undergo polyploidy or die. These cellular decisions are critical to maintaining liver cell replacement in disease, and in determining the likelihood of carcinogenesis in chronic liver injury. We show here that these proteins act both in concert and independently, demonstrating that a small set of key cellular players is common to diverse cell decisions of fundamental importance to disease.
Our results make two critical observations regarding the regulation of cell cycle commitment (G1/S progression) of growth-stimulated hepatocytes: firstly, basal p53 protein levels maintain a significant brake to hepatocyte proliferation by a mechanism dependent on p21. This suggests that the function of controlling proliferation assigned to activated p53 in stressed cells may also contribute to the maintenance of controlled proliferation in 'unstressed' cells. This is in agreement with a previous report (Tang et al., 1998) showing that, in normally proliferating cells, constitutive expression of p21 is regulated by p53. The regulation of p21 by basal levels of p53 may result from a small undetectable subset of the p53 population that is 'activated' for transcription -as known to occur after DNA damage. Whether this p53-, p21-and Rb-deficient liver cells S Sheahan et al effect is physiological or related to culture conditions remains to be determined.
Second, although wild-type hepatocyte cultures show only relatively low quantities of p21 protein by Western blot, p21 deficiency had a dramatic effect on BrdU labelling. This is not contradictory, however, since p21 is a potent inhibitor of cdks, and a single molecule of p21 can be sufficient to inhibit cdk2 activity . Our results are consistent with two mechanisms of control of proliferation by p21, one involving Rb, the other independent of Rb. The Rb-independent inhibition of replication may rely on different potential mechanisms: first, p21 can bind and inhibit the proliferating cell antigen (PCNA), which functions as a DNA-sliding clamp for polymerases d and e, and is an essential component of DNA replication (Paunesku et al., 2001) . Second, p21 inhibits Cyclin E/cdk2, which can induce S-phase entry independently of Rb-E2F (Lukas et al., 1997; Brugarolas et al., 1998) . Third, p21 can inhibit E2F independently of Rb (Dimri et al., 1996) and prevent the activity of c-Myc (Dotto, 2000) .
The pRb-dependent pathway involves the inhibition of pRb phosphorylation by p21, leading to the negative regulation of transcription factors E2Fs (reviewed in Harbour et al., 2000a, b) , overexpression of which induces S-phase entry (DeGregori et al., 1997). Interestingly, as previously described in other systems (Macleod et al., 1996; Tsai et al., 2002) , Rb-deficient hepatocytes exhibit a high level of p53 protein. The correspondingly increased p21 level contributes to a protective feedback on proliferation by boosting the p21-dependent pRb-independent pathway. When this feedback is absent (in p53À/À cells), the full potential capacity of Rb to restrict uncontrolled proliferation becomes apparent, with the proliferation rate in double null cells (RbÀ/Àp53À/À) higher than in RbÀ/À cells. The mechanism leading to p53 stabilization and activation as a transcription factor in our cells remains unknown. The transcription factor E2F can activate the expression of p14/p19ARF (DeGregori et al., 1997; Zhu et al., 1999) , whose interaction with mdm2 results Figure 7 Summary model. There are three major pathways of regulation of hepatocyte proliferation: the p21-Rb-dependent pathway (2), a p21-dependent-Rb-independent (3) and a pRbdependent, independent of the regulation by p21 (4). Basal p53 is also involved in the regulation of hepatocyte proliferation through a mechanism strictly dependent on p21 (1). Polyploidization is likely to result in part, simply from the increased proliferation rate of hepatocytes lacking p53, p21, or Rb (5). However, p53 also appears to specifically regulate polyploidization, perhaps via the G2/M checkpoint: cells lacking p21 re-enter S phase without undergoing mitosis, resulting in increased ploidy (6). p53 regulates centrosome duplication (8); hence deficiency may contribute to polyploidization in deficient cells. In the absence of Rb, increased p53 (7) provides a protective feedback by increasing the contribution of the Rb-independent pathway (3) Figure 6 Quantification of the number of centrosomes in mono-& binucleated hepatocytes of various genotypes. Centrosomes were manually counted different times after plating, as described in Materials and methods. The variation with time reflects the cell cycle. Note that, despite similar proliferation (Figure 2 ), p53À/À cells have a higher number of centrosomes than RbÀ/À cells p53-, p21-and Rb-deficient liver cells S Sheahan et al in p53 accumulation (Zhang et al., 2001) . However, our inability to detect changes in p19arf expression (data not shown) indicates that another mechanism may be involved, as recently suggested by Tsai et al. (2002) with RbÀ/À embryos. An effect of overexpressed E2F-1 to induce phosphorylation and stabilization of p53 cannot be excluded (Rogoff et al., 2002; Russell et al., 2002) . The observation of nuclear abnormalities in p53À/À and RbÀ/À but not p21À/À and wild-type cells is interesting. Coordinated regulation of both DNA and centrosome replication is required for bipolar spindle formation and correct segregation of chromosomes during mitosis .
As both functional p53 and pRb have previously been reported to be required for appropriate centrosome duplication (Meraldi et al., 1999; Mussman et al., 2000; Borel et al., 2002; Tarapore et al., 2002) , we postulated that dysregulation of both proliferation and centrosome duplication in cells lacking p53 or Rb could favor the formation of multipolar spindles and abnormal segregation of chromosomes that cause the observed nuclear and mitotic abnormalities. Intriguingly, centrosome number was not affected in cells lacking Rb. Alteration of centrosome function may be involved.
While loss of function of p53, pRb or p21 each led to uncontrolled proliferation, only p53 and Rb deficiency caused nuclear and mitotic abnormalities in the proliferating cells. It is therefore interesting to note that human liver cancers often show p53 and pRb mutation or allele loss, but not p21 mutation. The carcinogenic potential of p53 or pRb dysfunction in liver may therefore be more closely linked with their mitotic regulatory functions than a simple consequence of increased cell cycle entry and uncontrolled proliferation (Nigg, 2002) .
Polyploidy is prevalent in adult mouse liver, and slowly increases with age, predominantly through rounds of acytokinetic mitosis (binucleation) followed by a normal cell cycle, thus doubling the nuclear ploidy (Brodsky et al., 1977) . As the majority (about 80%) of hepatocytes isolated in our study are binucleated, the first round of replication is likely to increase the nuclear ploidy, whatever the genotype. The increased ploidy levels observed in p53À/À, p21À/À, pRbÀ/À or double null (p53À/ÀRbÀ/À) cells may therefore simply reflect the higher proliferation rate in these cells, compared with wild type. A direct effect of the gene deficiency is, however, obvious when comparing proliferation and ploidy levels between p21À/À and double null cells (p21À/Àp53À/À) (regardless of Rb genotype). While p21À/À and double null (p53À/Àp21À/À) cells show similar proliferation rates, ploidy is higher in p21À/À cells. Similarly, triple null cells exhibit the highest proliferation rate, but double null (RbÀ/Àp21À/À) cells are more polyploid. This suggests that the presence of wild-type p53 in p21À/À hepatocytes accentuates the polyploidization process. p53 is a known regulator of the G2/M transition (reviewed in Taylor et al. (2001) ). It indirectly inhibits cdc2, which is essential for entry into mitosis (Nurse, 1991) , through transcriptional activation of p21 (Smits et al., 2000) , Gadd45 (Wang et al., 1999) and 14-3-3s (Chan et al., 1999) . In p21À/À hepatocytes, the high level of p53 may still activate the G2/M checkpoint, while, in the absence of p21, premature accumulation of cyclinE-cdk2 activity cannot be prevented (Brugarolas et al., 1998) . Thus, in the absence of p21, the mitotic checkpoint might be intact but overridden by an imbalance of cyclins, providing a possible basis for endoreplication. This notion is supported by evidence that g-irradiated cells with high levels of p53 and inactive pRb and p21 undergo a temporary G2/M delay, after which they continued DNA replication resulting in endoreplication (Bulavin et al., 1999) .
Finally, the accumulation of p21 in RbÀ/À hepatocytes may promote endoreplication, as a consequence of the ability of p21 to inhibit mitosis (Roninson, 2002) but not S phase in the absence of pRb. This is consistent with previous studies linking elevated levels of p21 with increased liver ploidy (Wu et al., 1996) and overexpression of p21 in the absence of pRb with endoreplication (Niculescu et al., 1998) . Similarly, overexpression of Cyclin E, which is known to occur in Rb-deficient cells (Herrera et al., 1996) , is associated with increase in ploidy (Spruck et al., 1999) . This could certainly contribute to the phenotype of RbÀ/À hepatocytes.
It is widely accepted that Rb, p21 and p53 can regulate apoptosis in different tissues. Germ-line Rb deficiency caused widespread apoptosis in mouse embryos (Clarke et al., 1992) , which was p53-dependent or p53-independent, depending on the tissue (Bates et al., 1999; Hickman et al. (2002) and references therein). Our observation of increased apoptosis in growth-stimulated hepatocytes after Rb depletion is of further interest, since the apoptosis was p53-independent despite increased and transcriptionally active p53 in the cells. Furthermore, although inactivation of p21 has been reported to activate the mitochondrial pathway to apoptosis through upregulation and activation of p53 in human colon cancer cells (Javelaud et al., 2002) , this was not the case in p21À/À primary hepatocytes, despite elevated p53 (data not shown). This shows that, in contrast to other cell types (Macleod et al., 1996; Javelaud et al., 2002) , elevated and transcriptionally active p53 is not sufficient to induce p53-dependent apoptosis in hepatocytes.
In conclusion, our results show phenotypes not evident in resting liver, but that became rapidly manifest (one to two cell divisions) in primary cells stimulated to grow. They reveal collaborating but nonredundant inhibitory influences for cell cycle commitment, maintenance of growth arrest after DNA damage and regulation of cell death in authentic epithelial and nontransformed cells, an important consideration when studying the function of genes involved in cell cycle control. It is readily apparent how defects in one or more of these key proteins can critically alter the cell responses in a stimulated liver. The fact that many of the functions are consistent with other systems is important, as it demonstrates that these genes have a similar relevance across many cell types, including p53-, p21-and Rb-deficient liver cells S Sheahan et al well-differentiated epithelia, and therefore that disruption of their pathways may be fundamental to many different types of cancer.
Methods

Hepatocyte isolation, culture and adenovirus infection
Primary hepatocytes, from adult mice (male, 6-12-weeks old), were isolated by two-step retrograde perfusion (Renton et al., 1978; Kreamer et al., 1986) . Hepatocytes were plated onto fibronectin-coated plastic in serum-free modified Chee's Medium (Bellamy et al., 1997) .
The colony was obtained by crossing p53À/À (Purdie et al., 1994) , p21À/À (Deng et al., 1995) and Rb-floxed (Vooijs et al., 2002) to obtain all possible complex genotypes. The mice are inbred of mixed background. Rb-floxed mice are homozygous (Rb lox/lox ) for the Rb-floxed allele, whose exon 19 is flanked by LoxP sequences. RbÀ/À cells are obtained by deletion of the Rb-floxed alleles in vitro by infection with an adenovirus expressing Cre-recombinase (as previously described (Prost et al., 2001) ). Deletion of Rb is completed within 16-24 h after infection (Prost et al., 2001) . We have already reported that no toxicity is associated with the use of the adenovirus, whether empty or encoding the Cre-recombinase (Prost et al., 2001) .
In these conditions, we produce (wt, wt, FLOXED) mice whose cells are either untreated, treated by the adenovirus control (DL-70) for control purposes or Ad-cre to produce (Rb null) cells; (wt, p21null, FLOXED) from which we get the p21À/À cells, and the RbÀ/Àp21À/À after treatment with AdCre; (p53null, wt, FLOXED), from which we get the p53À/À cells, and the RbÀ/Àp53À/À after treatment with Ad-Cre, and finally the (p53null, p21null, FLOXED), from which we get p53À/Àp21À/À cells and triple null cells.
BrdU immunocytochemistry
Hepatocyte cultures grown on chamber slides (Lab-Tek) were incubated with 40 mM BrdU for 6 h and fixed in 80% ethanol. Immunodetection of BrdU incorporation was performed as previously described (Prost et al., 1998) using Rat anti-BrdU IgG (Sera Labs) 1/100 dilution as primary antibody and rabbit anti-rat IgG HRP conjugate 1/100 dilution as secondary. Slides were counterstained with hematoxylin and light green. BrdU incorporation was estimated by counting immunopositive cells.
Quantification of apoptosis, necrosis, mitosis and abnormal nuclei
Cells were Feulgen stained with a light-green counterstain. Briefly, cells were fixed in Boum's fixative at 41C overnight. Slides were treated with 5 M HCl for 45 min, then stained with Schiff reagent. Apoptosis and necrosis were quantified according to morphology: Apoptotic cells have condensed, uniformly refractile chromatin with retracted condensed cytoplasm (dark green), often with blebbing. Typically, apoptotic bodies are seen at a different plane of focus above normal cells (as defined by A Wyllie); necrotic cells have shrinked nuclei and damage cell membrane. Mitosis and abnormal nuclei were counted on Feulgen-and BrdU-stained slides, respectively.
Immunodetection of p21 and p53
Western blotting Total cell protein was prepared from primary hepatocytes using RIPA buffer, subjected to SDS-PAGE on a 10% (p53) or 14% (p21) gel, transferred to nitrocellulose, and probed with anti-p53 rabbit polyclonal (1 : 400) (Novocastra NCL-p53-CM5p), or anti-p21 goat polyclonal primary antibodies (1 : 200) (sc-471-G), and revealed by the appropriate HRP secondary antibody (1 : 2000) (Santa Cruz) and ECL.
Immunocytochemistry Hepatocytes were fixed in acetone/ methanol (1 : 1 v/v) for 5 min. Immunodetection of p53 was performed as described (Bellamy et al., 1997) , using an antip53 mouse monoclonal antibody (1 : 1000) (Oncogene Science), and revealed by a biotinylated rabbit anti-mouse secondary antibody (1 : 400) followed by an avidin-biotin HRP complex (Dako).
Centrosome labelling and quantification
Centrosomes of primary hepatocytes of different genotypes were labelled using a monoclonal antibody against U-tubulin (clone GTU-88, dilution 1/200) and Alexafluor (Molecular Probes) secondary antibody (1/2000). Quantification was performed by manual counting on appreciatively 25 representative fields ( Â 40) photographed using a Zeiss confocal microscope (LM510). Data were organized according to three categories of cells: mono-, bi and multinucleated cells. The 'multinucleated' group included all cells with more than two nuclei, and thus constitute a heterogeneous group.
Nuclear ploidy analysis
Hepatocytes were harvested in collagenase type 4 (0.5 mg/ml) 120 h after plating, resuspended in citrate buffer, and stained with propidium iodide, as described by Vindelov (Vindelov et al., 1983) . Nuclei were then subjected to flow cytometric analysis.
Transfection
Hepatocytes in culture for 24 h were transfected using Lipofectin reagent (Gibco) (ratio 1/3 w/w DNA/lipid, 1 mg of DNA per well). At the indicated time, cells were scraped and luciferase activity quantified using Luciferase Assay reagents, according to the manufacturer (Promega), and a luminometer. Reporter plasmids are pTA-Luc, pE2F-TA-Luc, pp53-TA-Luc and pRB-TA-Luc from the Mercuryt pathway profiling system (Clontech). Luciferase activity is given per mg of protein, as assessed using a Biorad assay.
Statistical analysis
Analyses were done with Minitab for Windows (version 13.0). For cell death studies, differences in medians were performed using the nonparametric Mann-Whitney test. For BrdU, p53, apoptosis and abnormal nuclei, the proportion of affected cells was Arcsin-transformed, and differences between means evaluated with analysis of variance (ANOVA). Differences were taken to be significant if Po0.05. Satisfactory homogeneity of variances was determined with Bartlett's test.
Abbreviations s.d., standard deviation; Rb-floxed, homozygote for floxed Rb; wt, wild-type or Rb-floxed cells treated with control adenovirus, or untreated; p21À/À, knockout for p21; p53À/À, knockout for p53; RbÀ/À, Rb-floxed cells p53-, p21-and Rb-deficient liver cells S Sheahan et al
